Why These 5 Stocks Are on the Move on Tuesday

3. Pfizer Inc. (NYSE:PFE) has declined 1.2% along with the market despite the company submitting data to the FDA from a phase 2/3 trial of their COVID-19 vaccine in children aged 5 to 11. Although the news is good for Pfizer, the stock often moves along with its sector, which is down due to the market. The number of elite funds in our database that were long Pfizer Inc. (NYSE:PFE) rose to 67 in the second quarter from 65 in the first quarter.